Randall W. Steinkampf

2-Substituted Aminopyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones. Structure−Activity Relationships Against Selected Tyrosine Kinases and in Vitro and in Vivo Anticancer Activity

S. KLUTCHKO, James M. Hamby, Diane H. Boschelli et al. · Journal of Medicinal Chemistry · 1998 · 130 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Anti-Angiogenic Activity of Selected Receptor Tyrosine Kinase Inhibitors, PD166285 and PD173074: Implications for Combination Treatment with Photodynamic Therapy

Charles J. Dimitroff, Wayne D. Klohs, Amarnath Sharma et al. · Investigational New Drugs · 1999 · 96 citations

Medicine, Oncology, Pharmacology +13

Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.

Wayne D. Klohs, Randall W. Steinkampf, Martha J. Havlick et al. · PubMed · 1986 · 68 citations

Medicine, Oncology, Pharmacology +15

The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in multiple drug-resistant cells.

Wayne D. Klohs, Randall W. Steinkampf · Molecular Pharmacology · 1988 · 65 citations

Medicine, Pharmacology, Cancer Pharmacology +15

Structure–activity relationships for 2-anilino-6-phenylpyrido[2,3-d]pyrimidin-7(8H)-ones as inhibitors of the cellular checkpoint kinase Wee1

Brian D. Palmer, Jeff B. Smaill, Gordon W. Rewcastle et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 60 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12